NeuroDerm

Israel
Reẖovot, Central District, Israel, 7670212

Company profile

NeuroDerm company profile

NeuroDerm is a clinical-stage pharmaceutical company developing next-generation treatments for central nervous system (CNS) disorders that will make a clinically meaningful difference in patients’ lives. NeuroDerm’s technology enables new routes of administration for existing drugs that overcome their current deficiencies and achieve enhanced clinical efficacy.

Business identity

Phone number
+972 8-946-2729
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Revenue range
$0+
Founded
2003-01-01, Year

Headquarters

Postal code
7670212
Country code
IL
Continent
Asia

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
4
Total equity funding
$170.5M
Last funding
Post IPO Equity / $75M / 2016-12-07
Last equity funding
Post IPO Equity / $75M
Investors
2
Lead investors
1
Founders
1
Articles
34
Exited on
2014-11-14

Founders and investors

Founders

Eli Heldman

Lead investors

The Elias Group

Investors

Robert TaubThe Elias Group